世界の抗下痢薬市場:成長動向・競争分析2020-2026

【英語タイトル】Global Anti Diarrheal Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00097)・商品コード:QYR20AP00097
・発行会社(調査会社):QYResearch
・発行日:2020年3月16日(※2024年版があります。お問い合わせください)
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、抗下痢薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗下痢薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(処方薬、OTC薬)、用途別市場規模(子ども、大人)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗下痢薬の種類別市場2015-2026:処方薬、OTC薬
・抗下痢薬の用途別市場2015-2026:子ども、大人
・抗下痢薬の北米市場分析
・抗下痢薬のアジア市場分析
・抗下痢薬の中南米市場分析
・抗下痢薬の中東・アフリカ市場分析
・関連企業情報:Actelion、Lupin、GSK、Glenmark Pharmaceuticals、Perrigo、Pfizer
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Anti Diarrheal Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti Diarrheal Drugs.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti Diarrheal Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti Diarrheal Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti Diarrheal Drugs market. Readers of the report can become informed about current and future trends of the global Anti Diarrheal Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti Diarrheal Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti Diarrheal Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti Diarrheal Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti Diarrheal Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti Diarrheal Drugs market is segmented into
Prescription Drugs
OTC Drugs

Market Segment by Application, the Anti Diarrheal Drugs market is segmented into
Children
Adults

This report includes the following manufacturers; we can also add the other companies as you want.
Actelion
Lupin
GSK
Glenmark Pharmaceuticals
Perrigo
Pfizer

The study objectives are:
To analyze and research the global Anti Diarrheal Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti Diarrheal Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti Diarrheal Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti Diarrheal Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti Diarrheal Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Prescription Drugs
1.3.3 OTC Drugs
1.4 Market Segment by Application
1.4.1 Global Anti Diarrheal Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Children
1.4.3 Adults
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti Diarrheal Drugs Revenue (2015-2026)
2.1.1 Global Anti Diarrheal Drugs Revenue (2015-2026)
2.1.2 Global Anti Diarrheal Drugs Sales (2015-2026)
2.2 Anti Diarrheal Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti Diarrheal Drugs Sales by Regions (2015-2020)
2.2.2 Global Anti Diarrheal Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anti Diarrheal Drugs Regions (Countries) Ranking by Market Size
2.4 Anti Diarrheal Drugs Industry Trends
2.4.1 Anti Diarrheal Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti Diarrheal Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti Diarrheal Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti Diarrheal Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anti Diarrheal Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti Diarrheal Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti Diarrheal Drugs Sales in 2019
3.2 Global Top Manufacturers Anti Diarrheal Drugs by Revenue
3.2.1 Global Anti Diarrheal Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti Diarrheal Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti Diarrheal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Diarrheal Drugs as of 2019)
3.4 Global Anti Diarrheal Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti Diarrheal Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti Diarrheal Drugs Market
3.7 Key Manufacturers Anti Diarrheal Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti Diarrheal Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anti Diarrheal Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anti Diarrheal Drugs Price by Type (2015-2020)
4.1 Global Anti Diarrheal Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti Diarrheal Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anti Diarrheal Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anti Diarrheal Drugs Price Forecast by Type (2021-2026)

5 Global Anti Diarrheal Drugs Market Size by Application
5.1 Global Anti Diarrheal Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anti Diarrheal Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anti Diarrheal Drugs Price by Application (2015-2020)
5.2 Global Anti Diarrheal Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti Diarrheal Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anti Diarrheal Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anti Diarrheal Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti Diarrheal Drugs Breakdown Data by Company
6.2 North America Anti Diarrheal Drugs Breakdown Data by Type
6.3 North America Anti Diarrheal Drugs Breakdown Data by Application
6.4 North America Anti Diarrheal Drugs Breakdown Data by Countries
6.4.1 North America Anti Diarrheal Drugs Sales by Countries
6.4.2 North America Anti Diarrheal Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti Diarrheal Drugs Breakdown Data by Company
7.2 Europe Anti Diarrheal Drugs Breakdown Data by Type
7.3 Europe Anti Diarrheal Drugs Breakdown Data by Application
7.4 Europe Anti Diarrheal Drugs Breakdown Data by Countries
7.4.1 Europe Anti Diarrheal Drugs Sales by Countries
7.4.2 Europe Anti Diarrheal Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Company
8.2 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Type
8.3 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Application
8.4 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anti Diarrheal Drugs Sales by Regions
8.4.2 Asia Pacific Anti Diarrheal Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti Diarrheal Drugs Breakdown Data by Company
9.2 Latin America Anti Diarrheal Drugs Breakdown Data by Type
9.3 Latin America Anti Diarrheal Drugs Breakdown Data by Application
9.4 Latin America Anti Diarrheal Drugs Breakdown Data by Countries
9.4.1 Latin America Anti Diarrheal Drugs Sales by Countries
9.4.2 Latin America Anti Diarrheal Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Type
10.2 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Application
10.3 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anti Diarrheal Drugs Sales by Countries
10.3.2 Middle East and Africa Anti Diarrheal Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Actelion
11.1.1 Actelion Corporation Information
11.1.2 Actelion Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Actelion Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Actelion Anti Diarrheal Drugs Products and Services
11.1.5 Actelion SWOT Analysis
11.1.6 Actelion Recent Developments
11.2 Lupin
11.2.1 Lupin Corporation Information
11.2.2 Lupin Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Lupin Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Lupin Anti Diarrheal Drugs Products and Services
11.2.5 Lupin SWOT Analysis
11.2.6 Lupin Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.3.3 GSK Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 GSK Anti Diarrheal Drugs Products and Services
11.3.5 GSK SWOT Analysis
11.3.6 GSK Recent Developments
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Corporation Information
11.4.2 Glenmark Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Glenmark Pharmaceuticals Anti Diarrheal Drugs Products and Services
11.4.5 Glenmark Pharmaceuticals SWOT Analysis
11.4.6 Glenmark Pharmaceuticals Recent Developments
11.5 Perrigo
11.5.1 Perrigo Corporation Information
11.5.2 Perrigo Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Perrigo Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Perrigo Anti Diarrheal Drugs Products and Services
11.5.5 Perrigo SWOT Analysis
11.5.6 Perrigo Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Pfizer Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Pfizer Anti Diarrheal Drugs Products and Services
11.6.5 Pfizer SWOT Analysis
11.6.6 Pfizer Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti Diarrheal Drugs Sales Channels
12.2.2 Anti Diarrheal Drugs Distributors
12.3 Anti Diarrheal Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.1.1 Global Anti Diarrheal Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti Diarrheal Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.2.2 North America Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti Diarrheal Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti Diarrheal Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anti Diarrheal Drugs Key Market Segments
Table 2. Ranking of Global Top Anti Diarrheal Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti Diarrheal Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Prescription Drugs
Table 5. Major Manufacturers of OTC Drugs
Table 6. Global Anti Diarrheal Drugs Market Share by Application 2019-2025 (K Units)
Table 7. Global Anti Diarrheal Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Anti Diarrheal Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Anti Diarrheal Drugs Sales Market Share by Regions 2015-2020
Table 10. Global Anti Diarrheal Drugs Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Anti Diarrheal Drugs Revenue Market Share by Regions 2015-2020
Table 12. Top Anti Diarrheal Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Anti Diarrheal Drugs Key Drivers: Impact Analysis (2021-2026)
Table 15. Anti Diarrheal Drugs Key Challenges
Table 16. Main Points Interviewed from Key Anti Diarrheal Drugs Players: Views for Future
Table 17. Global Anti Diarrheal Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Anti Diarrheal Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Anti Diarrheal Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Anti Diarrheal Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Global Anti Diarrheal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Diarrheal Drugs as of 2019)
Table 23. Key Manufacturers Anti Diarrheal Drugs Average Selling Price (ASP) (2015-2020) (USD/Units)
Table 24. Key Manufacturers Anti Diarrheal Drugs Plants/Factories Distribution
Table 25. Key Manufacturers Anti Diarrheal Drugs Area Served
Table 26. Date of Key Manufacturers Enter into Anti Diarrheal Drugs Market
Table 27. Key Manufacturers Anti Diarrheal Drugs Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prescription Drugs Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global OTC Drugs Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Anti Diarrheal Drugs Sales (K Units) by Type (2015-2020)
Table 32. Global Anti Diarrheal Drugs Sales Share by Type (2015-2020)
Table 33. Global Anti Diarrheal Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Anti Diarrheal Drugs Price (K Units) by Type (2015-2020)
Table 35. Global Anti Diarrheal Drugs Sales (K Units) by Type (2021-2026)
Table 36. Global Anti Diarrheal Drugs Sales Share by Type (2021-2026)
Table 37. Global Anti Diarrheal Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Anti Diarrheal Drugs Revenue Share by Type (2021-2026)
Table 39. Global Anti Diarrheal Drugs Price (K Units) by Type (2021-2026)
Table 40. Global Anti Diarrheal Drugs Sales (K Units) by Application (2015-2020)
Table 41. Global Anti Diarrheal Drugs Sales Share by Application (2015-2020)
Table 42. Global Anti Diarrheal Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Anti Diarrheal Drugs Price by Application 2015-2020 (USD/Units)
Table 44. Global Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 45. Global Anti Diarrheal Drugs Sales Share by Application (2015-2020)
Table 46. Global Anti Diarrheal Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Anti Diarrheal Drugs Revenue Share by Application (2021-2026)
Table 48. Global Anti Diarrheal Drugs Price (K Units) by Application (2021-2026)
Table 49. North America Anti Diarrheal Drugs Sales by Company (2015-2020) (K Units)
Table 50. North America Anti Diarrheal Drugs Sales Market Share by Company (2015-2020)
Table 51. North America Anti Diarrheal Drugs Sales by Type (2015-2020) (K Units)
Table 52. North America Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
Table 53. North America Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 54. North America Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
Table 55. North America Anti Diarrheal Drugs Sales by Countries (2015-2020) (K Units)
Table 56. North America Anti Diarrheal Drugs Sales Market Share by Countries (2015-2020)
Table 57. North America Anti Diarrheal Drugs Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Anti Diarrheal Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Anti Diarrheal Drugs Sales by Company (2015-2020) (K Units)
Table 60. Europe Anti Diarrheal Drugs Sales Market Share by Company (2015-2020)
Table 61. Europe Anti Diarrheal Drugs Sales by Type (2015-2020) (K Units)
Table 62. Europe Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
Table 63. Europe Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 64. Europe Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
Table 65. Europe Anti Diarrheal Drugs Sales by Countries (2015-2020) (K Units)
Table 66. Europe Anti Diarrheal Drugs Sales Market Share by Countries (2015-2020)
Table 67. Europe Anti Diarrheal Drugs Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Anti Diarrheal Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Anti Diarrheal Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Anti Diarrheal Drugs Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Anti Diarrheal Drugs Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Anti Diarrheal Drugs Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Anti Diarrheal Drugs Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Anti Diarrheal Drugs Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Anti Diarrheal Drugs Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Anti Diarrheal Drugs Sales by Company (2015-2020) (K Units)
Table 80. Latin America Anti Diarrheal Drugs Sales Market Share by Company (2015-2020)
Table 81. Latin America Anti Diarrheal Drugs Sales by Type (2015-2020) (K Units)
Table 82. Latin America Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
Table 83. Latin America Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 84. Latin America Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
Table 85. Latin America Anti Diarrheal Drugs Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Anti Diarrheal Drugs Sales Market Share by Countries (2015-2020)
Table 87. Latin America Anti Diarrheal Drugs Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Anti Diarrheal Drugs Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Anti Diarrheal Drugs Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Anti Diarrheal Drugs Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Anti Diarrheal Drugs Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Anti Diarrheal Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Anti Diarrheal Drugs Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Anti Diarrheal Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Actelion Company Details
Table 98. Actelion Description and Business Overview
Table 99. Actelion Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 100. Actelion Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 101. Actelion Anti Diarrheal Drugs Sales Market Share in Global Market
Table 102. Actelion Recent Development
Table 103. Lupin Company Details
Table 104. Lupin Description and Business Overview
Table 105. Lupin Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 106. Lupin Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 107. Lupin Anti Diarrheal Drugs Sales Market Share in Global Market
Table 108. Lupin Recent Development
Table 109. GSK Company Details
Table 110. GSK Description and Business Overview
Table 111. GSK Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 112. GSK Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 113. GSK Anti Diarrheal Drugs Sales Market Share in Global Market
Table 114. GSK Recent Development
Table 115. Glenmark Pharmaceuticals Company Details
Table 116. Glenmark Pharmaceuticals Description and Business Overview
Table 117. Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 118. Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 119. Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales Market Share in Global Market
Table 120. Glenmark Pharmaceuticals Recent Development
Table 121. Perrigo Company Details
Table 122. Perrigo Description and Business Overview
Table 123. Perrigo Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 124. Perrigo Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 125. Perrigo Anti Diarrheal Drugs Sales Market Share in Global Market
Table 126. Perrigo Recent Development
Table 127. Pfizer Company Details
Table 128. Pfizer Description and Business Overview
Table 129. Pfizer Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 130. Pfizer Anti Diarrheal Drugs Sales Growth Rate (2015-2020)
Table 131. Pfizer Anti Diarrheal Drugs Sales Market Share in Global Market
Table 132. Pfizer Recent Development
Table 133. Anti Diarrheal Drugs Distributors List
Table 134. Anti Diarrheal Drugs Customers List
Table 135. Global Anti Diarrheal Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 136. Global Anti Diarrheal Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 137. Global Anti Diarrheal Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 138. Global Anti Diarrheal Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 139. Global Anti Diarrheal Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 140. North America Anti Diarrheal Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 141. North America Anti Diarrheal Drugs Revenue Forecast by Countries 2021-2026
Table 142. Europe Anti Diarrheal Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 143. Europe Anti Diarrheal Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 144. Asia Pacific Anti Diarrheal Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 145. Asia Pacific Anti Diarrheal Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 146. Latin America Anti Diarrheal Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 147. Latin America Anti Diarrheal Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 148. Middle East and Africa Anti Diarrheal Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 149. Middle East and Africa Anti Diarrheal Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Diarrheal Drugs Product Picture
Figure 2. Global Anti Diarrheal Drugs Sales Market Shar by Type 2015-2026
Figure 3. Prescription Drugs Figures
Figure 4. OTC Drugs Figures
Figure 5. Global Anti Diarrheal Drugs Sales Market Share by Application in 2019 & 2026
Figure 6. Children Use Case
Figure 7. Adults Use Case
Figure 8. Anti Diarrheal Drugs Report Years Considered
Figure 9. Global Anti Diarrheal Drugs Market Size 2015-2026 (Million US$)
Figure 10. Global Anti Diarrheal Drugs Sales 2015-2020 (K Units)
Figure 11. Global Anti Diarrheal Drugs Market Size Market Share by Regions 2015-2020
Figure 12. Global Anti Diarrheal Drugs Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Anti Diarrheal Drugs Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti Diarrheal Drugs Sales in 2019
Figure 16. Anti Diarrheal Drugs Value Share by Manufacturers in 2019
Figure 17. Anti Diarrheal Drugs Revenue Share by Manufacturers In 2019
Figure 18. Anti Diarrheal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Anti Diarrheal Drugs Revenue Share by Type (2015-2020)
Figure 20. Global Anti Diarrheal Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Anti Diarrheal Drugs Market Share by Price Range (2015-2020)
Figure 22. Global Anti Diarrheal Drugs Revenue Share by Application (2015-2020)
Figure 23. Global Anti Diarrheal Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Anti Diarrheal Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Anti Diarrheal Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Anti Diarrheal Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Anti Diarrheal Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Anti Diarrheal Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Anti Diarrheal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Actelion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Anti Diarrheal Drugs Value Chain
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. North America Anti Diarrheal Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 63. North America Anti Diarrheal Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Europe Anti Diarrheal Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. Europe Anti Diarrheal Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Asia Pacific Anti Diarrheal Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Asia Pacific Anti Diarrheal Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Latin America Anti Diarrheal Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Latin America Anti Diarrheal Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Middle East and Africa Anti Diarrheal Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Middle East and Africa Anti Diarrheal Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed


【掲載企業】

Actelion、Lupin、GSK、Glenmark Pharmaceuticals、Perrigo、Pfizer

★調査レポート[世界の抗下痢薬市場:成長動向・競争分析2020-2026] (コード:QYR20AP00097)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗下痢薬市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆